Ascendis Pharma

Perfil de la empresa

Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.

Descripción disponible en inglés.

Datos societarios

Sector

Salud

Industria

Biotechnology

País

Estados Unidos

Sede

Tuborg Boulevard 12, 2900, Hellerup

Empleados

1.189

Cotización

ASND · NASDAQ

Divisa

USD

Sitio web

ascendispharma.com